title: Can Rinvoq and Skyrizi Sales Drive Another Strong Quarter for AbbVie?
source: Yahoo
date: 2025-10-14
url: https://finnhub.io/api/news?id=6a8b7af46b3d6cfb0ab5527d9dc920b0d4a2f26f7e6667e176ab5929df99e608
ABBV leans on booming Skyrizi and Rinvoq-driven sales to sustain growth and counter Humira's decline as Q3 results approach.
